NeuroLife® Launch Brings Non-Invasive Technology Aimed at Restoring Hand and Arm Movement After Stroke and Spinal Cord Injury
Summary
NeuroLife launches as a non-invasive neurotechnology company focused on wearable rehabilitation for stroke and spinal cord injury recovery. The company closed a $2.9 million seed round backed by Battelle and The NeuroTech Institute, and it also has licensed Battelle’s platform technology. Its wearable sleeve reads neuromuscular signals, interprets movement intent, and delivers stimulation to support hand and arm function during therapy. NeuroLife is pursuing FDA clearance and clinical validation while building commercial scalability. The company is also seeking co-development, clinical pilot, and strategic investment partners.
Funding
Amount
$2.9M
Total raised
Date
June 25, 2026
Announcement date
Investors
Battelle
Lead investors
Company
https://www.neurolifetech.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected